A New Scoring Algorithm to Assess the Prognosis of Primary and Metastatic Breast Cancer with HER2-low Expression

被引：0
|
作者：
Miao, Jiaxian [1 ]
Shang, Jiuyan [1 ]
Liu, Yueping [1 ]
机构：
[1] Hebei Med Univ, Hosp 4, Shijiazhuang, Hebei, Peoples R China
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
187
引用
收藏
页码：S222 / S224
页数：3
相关论文
共 50 条
  • [41] Study of HER2-low expression in triple-negative breast cancer
    Trung, T. Tran
    Ngoc, A. Duong Thi
    Van, T. Nguyen
    Van, T. Ta
    BREAST, 2025, 80
  • [42] Genomic landscape of circulating tumor DNA in HER2-low metastatic breast cancer
    Yi, Zongbi
    Feng, Kaixiang
    Lv, Dan
    Guan, Yanfang
    Shao, Youcheng
    Ma, Fei
    Xu, Binghe
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [43] Clinical outcomes in women with metastatic HER2-Low breast cancer in the real world
    Jiang, Changchuan
    Perimbeti, Stuthi
    Deng, Lei
    Shapiro, Charles L.
    Gandhi, Shipra
    CANCER RESEARCH, 2022, 82 (12)
  • [44] Effect of HER2-low expression on neoadjuvant efficacy in operable breast cancer
    Yi, Xiaoli
    Hu, Shasha
    Ma, Meili
    Huang, Dongshuai
    Zhang, Yan
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (04): : 880 - 890
  • [45] Trastuzumab Deruxtecan in HER2-Low Breast Cancer
    Carroll, Hailey K.
    Higgins, Michaela J.
    O'Reilly, Seamus
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (12): : 1144 - 1144
  • [46] A gene expression-based classifier for HER2-low breast cancer
    Di Cosimo, Serena
    Pizzamiglio, Sara
    Ciniselli, Chiara Maura
    Duroni, Valeria
    Cappelletti, Vera
    de Cecco, Loris
    De Santis, Maria Carmen
    Orlandi, Rosaria
    Iorio, Marilena
    Silvestri, Marco
    Pruneri, Giancarlo
    Verderio, Paolo
    CANCER RESEARCH, 2024, 84 (09)
  • [47] Effect of HER2-low expression on neoadjuvant efficacy in operable breast cancer
    Xiaoli Yi
    Shasha Hu
    Meili Ma
    Dongshuai Huang
    Yan Zhang
    Clinical and Translational Oncology, 2024, 26 : 880 - 890
  • [48] Prognostic and biologic significance of HER2-low expression in early breast cancer
    Tarantino, P.
    Jin, Q.
    Tayob, N.
    Jeselsohn, R.
    Schnitt, S. J.
    Vincuilla, J.
    Parker, T.
    Tyekucheva, S.
    Lin, N. U.
    Hughes, M.
    Weiss, A. C.
    King, T. A.
    Mittendorf, E. A.
    Curigliano, G.
    Tolaney, S. M.
    ANNALS OF ONCOLOGY, 2022, 33 : S124 - S124
  • [49] Dynamics of HER2-low expression in triple-negative breast cancer
    Garrido-Castro, Ana C.
    Ngo, Lan D.
    Richardson, Edward T.
    Frangieh, Allison
    Mohammed-Abreu, Ayesha
    Hughes, Melissa E.
    Zanudo, Jorge Gomez Tejada
    Navarro, John
    Tarantino, Paolo
    Mittendorf, Elizabeth A.
    Tolaney, Sara
    King, Tari
    Winer, Eric
    Lin, Nancy U.
    Wagle, Nikhil
    CANCER RESEARCH, 2023, 83 (05)
  • [50] A gene expression-based classifier for HER2-low breast cancer
    Serena Di Cosimo
    Sara Pizzamiglio
    Chiara Maura Ciniselli
    Valeria Duroni
    Vera Cappelletti
    Loris De Cecco
    Cinzia De Marco
    Marco Silvestri
    Maria Carmen De Santis
    Andrea Vingiani
    Biagio Paolini
    Rosaria Orlandi
    Marilena Valeria Iorio
    Giancarlo Pruneri
    Paolo Verderio
    Scientific Reports, 14
12345